Songyan Liao
Cardiology Division,
Department of Medicine,
Queen Mary Hospital,
Shenzhen Institutes of Research and Innovation,
Cardiology Division, Department of Medicine, Queen Mary Hospital
University of Hong Kong
Liao Songyan, M.D., Ph.D. is a Research Assistant Professor in the Department of Medicine, The University of Hong Kong, Hong Kong. His current research is centered on stem cell therapy for cardiovascular disease. Dr. Liao obtained his Ph.D. from the Department of Medicine at The University of Hong Kong in 2013, under the supervision of Prof. Tse Hung Fat. He finished his postdoctoral training from 2014 to 2017 before taking a Research Assistant Professor position in same institution. Dr. Liao’s lab has nearly twenty years experiences in small and big animal surgery in cardiovascular system and stem cell therapy for myocardial infarction and heart failure. His current work focuses on cardiac tissue engineering for heart regeneration.
Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium.
European journal of heart failure Aug, 2007 | Pubmed ID: 17481945
MR diffusion tensor imaging study of postinfarct myocardium structural remodeling in a porcine model.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine Oct, 2007 | Pubmed ID: 17899595
MR study of the effect of infarct size and location on left ventricular functional and microstructural alterations in porcine models.
Journal of magnetic resonance imaging : JMRI Feb, 2009 | Pubmed ID: 19161181
Determinants of lesion dimensions during transcatheter microwave ablation.
Pacing and clinical electrophysiology : PACE Feb, 2009 | Pubmed ID: 19170909
Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
Cell transplantation , 2012 | Pubmed ID: 22776744
Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.
Clinical science (London, England : 1979) Aug, 2015 | Pubmed ID: 25849791
Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy.
Scientific reports Jun, 2015 | Pubmed ID: 26057572
iPSC-MSCs with High Intrinsic MIRO1 and Sensitivity to TNF-α Yield Efficacious Mitochondrial Transfer to Rescue Anthracycline-Induced Cardiomyopathy.
Stem cell reports 10, 2016 | Pubmed ID: 27641650
Elevated plasma interleukin-37 playing an important role in acute coronary syndrome through suppression of ROCK activation.
Oncotarget Feb, 2017 | Pubmed ID: 28039466
Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
Stem cell research & therapy 03, 2019 | Pubmed ID: 30845990
